Staphylococcus epidermidis sepsis in pediatric patients: clinical and therapeutic considerations

Area of Science:

• Pediatric Infectious Diseases
• Medical Microbiology

Background:

• Staphylococcus epidermidis, once a contaminant, is now a significant pathogen in vulnerable pediatric populations.
• Hospitalized, immunosuppressed, premature, and malnourished children are at increased risk.
• Indwelling medical devices, particularly catheters, are common sources of S. epidermidis sepsis.

Purpose of the Study:

• To analyze the clinical presentation, sources, and outcomes of Staphylococcus epidermidis sepsis in 60 pediatric patients.
• To evaluate the effectiveness of vancomycin in treating S. epidermidis sepsis, especially in catheter-related infections.

Main Methods:

• Retrospective review of 60 pediatric patients diagnosed with S. epidermidis sepsis.
• Analysis of patient demographics, primary diagnoses, clinical symptoms, and identified sources of infection.
• Assessment of treatment regimens, focusing on vancomycin efficacy and outcomes, including mortality and catheter clearance.

Main Results:

• Fever was the most common clinical presentation (54/60 patients).
• Central venous catheters (percutaneous and Broviac) were the most frequent sources of infection (40/56 patients with a documented source).
• Six sepsis-related deaths occurred, primarily in premature infants. Vancomycin demonstrated efficacy in clearing S. epidermidis from infected Broviac catheters (20/23) and subclavian catheters (2/6).

Conclusions:

• Staphylococcus epidermidis is an emergent and serious pathogen in pediatric patients, particularly those with indwelling catheters.
• Aggressive antimicrobial therapy, with vancomycin showing effectiveness, is crucial for managing S. epidermidis sepsis.
• Prompt diagnosis and treatment are vital to reduce morbidity and mortality associated with this infection.